{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:46:43Z","timestamp":1790192803537,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T00:00:00Z","timestamp":1437350400000},"content-version":"vor","delay-in-days":3671,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.bbmt.2005.04.007","type":"journal-article","created":{"date-parts":[[2005,6,19]],"date-time":"2005-06-19T07:07:29Z","timestamp":1119164849000},"page":"551-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Sirolimus and Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"11","author":[{"given":"Corey","family":"Cutler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Lynn","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Magee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haesook T.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Alyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2005.04.007_bib1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V73.6.1729.1729","article-title":"Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia","volume":"73","author":"Storb","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.04.007_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbmt.2005.02.006","article-title":"Mucositis after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/bbmt.2001.v7.pm11349809","article-title":"Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation","volume":"7","author":"Ho","year":"2001","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1083-8791(00)70007-3","article-title":"Equivalence of 2 effective graft-versus-host disease prophylaxis regimens","volume":"6","author":"Chao","year":"2000","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib5","first-page":"85","article-title":"Omission of day +11 methotrexate after matched-related allogeneic peripheral blood stem cell transplantation does not increase the risk of graft-vs.-host disease","volume":"8","author":"Cutler","year":"2002","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1703710","article-title":"Transplantation-associated thrombotic microangiopathy","volume":"30","author":"Daly","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jca.10030","article-title":"Thrombotic microangiopathies in bone marrow and organ transplant patients","volume":"17","author":"McLeod","year":"2002","journal-title":"J Clin Apheresis."},{"key":"10.1016\/j.bbmt.2005.04.007_bib8","first-page":"495","article-title":"Thrombotic microangiopathy following bone marrow transplantation","volume":"14","author":"Pettitt","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.02699.x","article-title":"The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation","volume":"113","author":"Fuge","year":"2001","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2005.04.007_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1701830","article-title":"Severe thrombotic microangiopathy","volume":"24","author":"Iacopino","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bmt.1701359","article-title":"Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis","volume":"22","author":"Paquette","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib12","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1046\/j.1365-2141.2002.03721.x","article-title":"Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation","volume":"118","author":"Ruutu","year":"2002","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2005.04.007_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2005.04.007_bib14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.TP.0000118413.92211.B6","article-title":"Sirolimus-associated pulmonary toxicity","volume":"77","author":"Pham","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.04.007_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00007890-199902270-00009","article-title":"FK506-associated thrombotic microangiopathy","volume":"67","author":"Trimarchi","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.04.007_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1034\/j.1399-0012.2000.140204.x","article-title":"Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients","volume":"14","author":"Basara","year":"2000","journal-title":"Clin Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib17","first-page":"25","article-title":"The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis","volume":"3","author":"Devine","year":"1997","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.bmt.1701983","article-title":"Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation","volume":"24","author":"Przepiorka","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1704594","article-title":"Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation","volume":"34","author":"Uberti","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib20","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.04.007_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00041552-200211000-00006","article-title":"Sirolimus (Rapamune) in renal transplantation","volume":"11","author":"Johnson","year":"2002","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"10.1016\/j.bbmt.2005.04.007_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0022-5223(99)70291-6","article-title":"Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection","volume":"117","author":"Longoria","year":"1999","journal-title":"J Thorac Cardiovasc Surg."},{"key":"10.1016\/j.bbmt.2005.04.007_bib23","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/S0041-1345(03)00234-3","article-title":"Sirolimus in liver transplantation","volume":"35","author":"Trotter","year":"2003","journal-title":"Transplant Proc."},{"key":"10.1016\/j.bbmt.2005.04.007_bib24","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood-2003-02-0489","article-title":"Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation","volume":"102","author":"Antin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.04.007_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","article-title":"Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation","volume":"10","author":"Cutler","year":"2004","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0272-6386(03)00424-4","article-title":"Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient","volume":"42","author":"Barone","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.bbmt.2005.04.007_bib27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00007890-200203150-00017","article-title":"De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination","volume":"73","author":"Langer","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.04.007_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.TP.0000092522.36410.D0","article-title":"Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation","volume":"77","author":"Paramesh","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.04.007_bib29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1034\/j.1600-6143.2003.00051.x","article-title":"Thrombotic micro-angiopathy with sirolimus-based immunosuppression","volume":"3","author":"Robson","year":"2003","journal-title":"Am J Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1600-6143.2003.00018.x","article-title":"Sirolimus may promote thrombotic microangiopathy","volume":"3","author":"Saikali","year":"2003","journal-title":"Am J Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib31","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/00007890-200112270-00010","article-title":"Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease","volume":"72","author":"Benito","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2005.04.007_bib32","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.2337\/diacare.26.11.3191","article-title":"Sirolimus-induced interstitial pneumonitis in an islet transplant recipient","volume":"26","author":"Digon","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbmt.2005.04.007_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4065\/79.4.541","article-title":"Sirolimus-associated diffuse alveolar hemorrhage","volume":"79","author":"Vlahakis","year":"2004","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.bbmt.2005.04.007_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1083-8791(03)80016-2","article-title":"Sirolimus (rapamycin) for treatment of steroid-refractory chronic graft versus host disease","volume":"9","author":"Couriel","year":"2003","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib35","first-page":"87","article-title":"Rapamycin for treatment of chronic graft versus host disease","volume":"8","author":"Johnston","year":"2002","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib36","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1093\/ndt\/13.12.3153","article-title":"Enhancement of human platelet aggregation and secretion induced by rapamycin","volume":"13","author":"Babinska","year":"1998","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib37","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0041-1345(00)02427-1","article-title":"Pharmacokinetic interactions between sirolimus and cyclosporine exacerbate renal dysfunction","volume":"33","author":"Podder","year":"2001","journal-title":"Transplant Proc."},{"key":"10.1016\/j.bbmt.2005.04.007_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0009-9120(93)90118-P","article-title":"Comparison of the effect of rapamycin and FK506 on release of prostacyclin and endothelin in vitro","volume":"26","author":"Yatscoff","year":"1993","journal-title":"Clin Biochem."},{"key":"10.1016\/j.bbmt.2005.04.007_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4065\/78.4.421","article-title":"Posttransplantation thrombotic thrombocytopenic purpura","volume":"78","author":"Elliott","year":"2003","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.bbmt.2005.04.007_bib40","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood.V93.11.3798","article-title":"von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura","volume":"93","author":"van der Plas","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.04.007_bib41","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1080\/1042819021000015862","article-title":"Thrombotic thrombocytopenic purpura following stem cell transplantation","volume":"43","author":"Allford","year":"2002","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.bbmt.2005.04.007_bib42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.thj.6200127","article-title":"Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy","volume":"2","author":"Arai","year":"2001","journal-title":"Hematol J."},{"key":"10.1016\/j.bbmt.2005.04.007_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.04.007_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1473-0502(02)00020-4","article-title":"Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver","volume":"27","author":"Daly","year":"2002","journal-title":"Transfus Apheresis Sci."},{"key":"10.1016\/j.bbmt.2005.04.007_bib45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bmt.1702849","article-title":"Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation","volume":"27","author":"Roy","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib46","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","article-title":"Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation","volume":"73","author":"Holler","year":"1989","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2005.04.007_bib47","first-page":"51","article-title":"Effects of defibrotide in acute renal failure due to thrombotic microangiopathy","volume":"16","author":"Vangelista","year":"1986","journal-title":"Haemostasis"},{"key":"10.1016\/j.bbmt.2005.04.007_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000190340","article-title":"Effect of a new antithrombotic agent (defibrotide) in acute renal failure due to thrombotic microangiopathy","volume":"40","author":"Bonomini","year":"1985","journal-title":"Nephron"},{"key":"10.1016\/j.bbmt.2005.04.007_bib49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02983218","article-title":"Clinical significance of fragmented red cells after allogeneic bone marrow transplantation","volume":"77","author":"Kanamori","year":"2003","journal-title":"Int J Hematol."},{"key":"10.1016\/j.bbmt.2005.04.007_bib50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1704601","article-title":"Automated measurement of schistocytes after bone marrow transplantation","volume":"34","author":"Lesesve","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2005.04.007_bib51","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1701442","article-title":"Red cell fragmentation (schistocytosis) after bone marrow transplantation","volume":"22","author":"Zomas","year":"1998","journal-title":"Bone Marrow Transplant."}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105002636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105002636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:23:52Z","timestamp":1761056632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879105002636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S1083879105002636"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.04.007","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus and Thrombotic Microangiopathy after Allogeneic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}